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Abstract 
Introduction: Assuming that spina bifida (SB) is a genetically controlled disease,
the aim of our study was to evaluate the degree of genetic homozygosity and
the distribution of AB0 blood types among patients with SB occulta and SB
aperta by the homozygously recessive characteristics (HRC) test. 
Material and methods: Our study included an analysis of the presence,
distribution and individual combination of 15 selected genetically controlled
morpho-physiological traits in a sample of 100 patients with SB (SB occulta 
N = 50 and SB aperta N = 50) and a control group of individuals (N = 100). 
Results: We found a statistically significant difference between the mean values
for genetic homozygosity (SB 4.5 ±0.3; control 3.0 ±0.2, p < 0.001) and also
differences in the presence of certain individual combinations of such traits. In
12 (80.0%) of the 15 observed characteristics, recessive homozygosity was
expressed to a greater degree among the group of SB patients, while for 
9 (60.0%) of the traits this level of difference was statistically significant 
(Σχ2 = 266.3, p < 0.001). There was no difference in average homozygosity of
such genetic markers between groups of SB occulta and SB aperta patients, but
the type of individual variation in the two studied groups significantly differed.
In the group of patients with SB the frequency of 0 blood group was significantly
increased while B blood group was significantly decreased. 
Conclusions: Our results clearly show that there is a populational genetic
difference in the degree of genetic homozygosity and variability between the
group of patients with SB and individuals without clinical manifestations,
indicating a possible genetic component in the aetiopathogenesis of spina bifida.
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Introduction
Spinal dysraphism (spina bifida – SB) is a congenital deformity involving
failure of normal midline fusion of the neural tube. The aetiology of SB is
still unknown, but there is evidence suggesting multifactorial origin [1, 2].
A genetic component has been evaluated as a possible factor governing
formation of SB including specific chromosomal or single-gene disorders
[1, 3, 4]. The role of environmental factors including folic acid, vitamin B12,
infection, drugs, etc., has also been studied [1, 5, 6]. 
Corresponding author:
Dejan Nikolic, MD, MSc
Physical Medicine and
Rehabilitation Department
University Children’s Hospital
Nikole Stefanovica 3
11000 Belgrade, Serbia
Phone: +38 16 381 333 45
E-mail: denikol27@yahoo.com
Basic research
1Physical Medicine and Rehabilitation Department, University Childrens Hospital,
Belgrade, Serbia
2Institute for Human Genetics, Medical Faculty, University of Belgrade, Serbia 
3Pediatric Surgery Department, University Children’s Hospital, Belgrade, Serbia
Submitted: 10 March 2010
Accepted: 25 May 2010
Arch Med Sci 2010; 6, 6: 854-859
DOI: 10.5114/aoms.2010.19291 
Copyright © 2010 Termedia & BanachThe genes which are so far known to be involved
in determining susceptibility to SB are 1p13, 6q27,
and 17q11.20q12 (OMIM number 182940), followed
by 1p36.3, 1q43, 5p15.3-p15.2 and 14q24 (OMIM
number 601634), while some studies have
suggested X-linked inheritance (OMIM number
301410) [7]. 
Assuming that SB is a genetically controlled
disease, we made the hypothesis that a generally
increased homozygosity level, as well as changed
variability in the samples of such patients, could be
population-genetic parameters for the prediction
of this illness. 
Since we know only a small number of loci
determining a specific morpho-physiological
character, it is very delicate to estimate genetic
homozygosity in humans. But knowing the type of
inheritance and variability, it can be seen that
a series of morpho-physiological traits are under
the control of one or a small number of genes.
Several studies, which established distribution and
frequency of a series of extremely expressed
recessive traits, show quite a difference in the
presence of such traits among observed groups of
individuals (i.e. comparison between ill and healthy
individuals, pupils from special and regular schools,
carriers of different blood types) [8-16].
The studied homozygous recessive charac  -
teristics (HRC) are obviously controlled by genes
located on different human chromosomes, so they
could be considered as markers of those
chromosomes, as well as of numerous surrounding
genes controlling different components of fitness.
The amount of recessive homozygosity estimated
by our HRC test is practically an estimation of
genetic loads present in the human population, or
in any specific sample of human individuals [11-15].
Numerous studies show that the percentage of
the AB0 blood types was found to be quite different
in different samples of patients [13, 17-23].
According to the findings, we assumed that there
may be a certain connection between the
predisposition to SB and the frequencies of AB0
blood types.
Material and methods
The HRC test for determination of genetic
homozygosity in humans [8, 9] has been developed
in order to define the proportion of homozygously
recessive clearly expressed characteristics in 
every individual as markers of chromosomal
homozygosities. Selected groups of people, such as
a healthy control group and a sample of individuals
affected by a specific disease, are compared. If they
have different amounts of homo-recessive traits,
this would be a manifestation of a kind of genetic
load which will be present in the selected samples
of the studied population [11-15]. 
The HRC test is a highly suitable method for
estimating individual homozygosity by direct
observation of defined phenotypic traits, and it takes
only a few minutes to analyse the presence of 
15 characteristics of the person observed (Table I).
The presence of the studied genetically controlled
recessive characteristics was used as a parameter
for homozygosity of the corresponding genes and
chromosomes.
Some homozygously recessive traits in the region
of the human head are, for example: unattached
ear lobe (OMIM number 128900), continuous frontal
hair line (OMIM number 194000), blue eyes (gene
location 19p13.1-q13.11, OMIM number 227240),
straight, soft and blond hair (OMIM numbers
139450 and 210750), double hair whorl, opposite
hair whorl orientation (OMIM number 139400), 
as well as an inability to roll, fold and curve the
tongue (OMIM number 189300), a guttural “r”,
insensitivity to PTC (phenylthiocarbamide) (gene
location 7q35-q36, OMIM number 607751) and
Daltonism (gene location Xq28, OMIM number
303800). Such traits are also clearly expressed in
human arms and legs, such as distal or proximal
hyperextensibility of the thumb, index finger longer
than the ring finger (OMIM number 136100), left-
handedness (gene location 2p12-q22, OMIM
number 139900), hand clasping pattern (OMIM
number 139800), absence of mid-digital hair (OMIM
number 157200), etc. [7]. 
In this study, comparative analyses were made
by the same person, with equal criteria for
determining extremely pronounced homozygously
recessive characteristics by direct observation in
tested groups of individuals. Variations in the
presence of such characteristics were estimated
using standard statistical procedures, and by
comparing the means, the variances, and shapes
of the distribution between the affected and healthy
individuals. We used common tests to determine
the differences in the mean values, scope and 
type of variability (Mann-Whitney U test, and χ2
respectively).
Both groups of tested individuals (SB patients
and controls) belong to the same ethnic group
(Serbian population). The group of SB patients
consisted of 100 individuals (aged between 3 and
16) who were treated in the University Children’s
Hospital in Belgrade. The control sample consisted
of 100 randomly chosen children from Belgrade,
belonging to the same age group and from the
same locality. Since previous confirmation of spinal
dysraphism with imaging techniques and clinical
evaluation had been done by physicians, the group
of SB patients was divided into the subgroups of
SB occulta patients (SBO, N = 50) and SB aperta
patients (SBA, N = 50).
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tested groups were undertaken with the assistance
of the Saint Sava Institute for blood transfusion
from Belgrade in Serbia. 
For interpretation of the results in our study,
a value of p < 0.05 was considered to be statistically
significant.
Results
From the data presented (Table I, Figure 1), it can
be seen that HRC testing of SB patients shows an
increased average homozygosity of the studied
genetic markers, in comparison with healthy control
individuals. It is obvious that the mean value of 
HRC in the complete sample of SB patients is
significantly higher (p < 0.001) than in the control
group (SB: 4.5 ±0.3, control: 3.0 ±0.2). In 12 (80.0%)
(blond hair, continuous hairline, straight hair, soft
hair, double hair whorl, opposite hair whorl
orientation, ear without Darwinian knot, blue eyes,
top joint of the thumb > 45°, proximal thumb
extensibility, left-handedness and index finger
longer than the ring finger) out of 15 observed
characters, recessive homozygosity was expressed
to a greater degree among SB patients, and in 
9 (60.0%) (blond hair, continuous hairline, straight
hair, soft hair, opposite hair whorl orientation, ear
without Darwinian knot, blue eyes, top joint of the
thumb > 45° and proximal thumb extensibility) of
these characteristics this difference was statistically
significant (p < 0.01 for continuous hairline, blue
eyes and top joint of the thumb > 450, and 
p < 0.001 for the rest of the traits), while only 
3 (20.0%) (attached ear lobe, colour blindness and
right thumb over left thumb) are more frequent in
the control group of individuals (Table I). The type
Homozygously recessive characteristics Control sample Spina bifida affected χ2
N = 100, n (%) N = 100, n (%)
Blond hair 9 (9) 45 (45) 144**
Continuous hairline 30 (30) 45 (45) 7.5*
Straight hair 41 (41) 67 (67) 16.5**
Soft hair 36 (36) 59 (59) 14.7**
Double hair whorl 6 (6) 8 (8) 0.7
Opposite hair whorl orientation 6 (6) 15 (15) 13.5**
Attached ear lobe 23 (23) 8 (8) 9.8**
Ear without Darwinian knot 1 (1) 5 (5) 16.0**
Blue eyes 21 (21) 33 (33) 6.9*
Colour blindness 3 (3) 2 (2) 0.3
Right thumb over left thumb 43 (43) 36 (36) 1.1
Top joint of the thumb > 45° 24 (24) 37 (37) 7.0*
Proximal thumb extensibility 9 (9) 23 (23) 21.8**
Left-handedness 13 (13) 20 (20) 3.8
Index finger longer than the ring finger 30 (30) 39 (39) 2.7
Σχ2 = 266.3**
*p < 0.01, **p < 0.001  
Control: N = 100, x –
hro/15 = 3.0 ±0.2 
Affected: N = 100, x –
hro/15 = 4.5 ±0.3 (z = 6.80, p < 0.001) 
Table I. Frequencies of homozygously recessive characteristics among patients with spina bifida and individuals of
control sample
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Figure 1.  Frequencies of homozygous recessive
characteristics in the group of patients with spinal
dysraphism and the control group 
Control: N = 100, x –
hro/15 = 3.0 ±0.2 
Affected: N = 100, x –
hro/15 = 4.5 ±0.3 (z = 6.80, 
p < 0.001) 
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significantly differed (Σχ2 = 266.3, df = 14), showing
that their genetic dispositions were remarkably
different. Almost three quarters of SB patients had
four or more homo-recessive characteristics,
whereas among the control group almost three
quarters of individuals had less than four homo-
recessive characteristics.
Observing the distribution of HRC frequency
between SB patients and the control sample of
individuals, it can be seen that HRC in the group of
SB patients are moving toward higher values,
suggesting that genetic disposition at the polygenic
level exists between two tested samples (Figure 1).
From the data presented (Table II) it can be seen
that there is no difference in average homozygosity
of such genetic markers between groups of SBO
and SBA patients. In 8 (53.3%) (straight hair, double
hair whorl, attached ear lobe, ear without Darwinian
knot, right thumb over left thumb, top joint of the
thumb > 45°, left-handedness and index finger
longer than the ring finger) out of 15 observed
characters, recessive homozygosity was expressed
to a greater degree among SBO patients, and in 
2 (13.3%) (right thumb over left thumb and top joint
of the thumb > 45°) of these characteristics this
difference was statistically significant (p < 0.05). In
the group of SBA patients 6 (40.0%) (blond hair,
continuous hairline, soft hair, opposite hair whorl
orientation, blue eyes and proximal thumb
extensibility) out of 15 recessive characters are more
frequent, and in 1 (6.7%) (blue eyes) of these
characteristics this difference was statistically
significant (p < 0.001). The type of individual
variation in the two studied groups significantly
differed (Σχ2 = 40.9, df = 14). 
As for the distribution of HRC frequency between
groups of SBO and SBA patients, it can be seen that
HRC in the group of SBA patients have a slight
tendency towards higher values (z = 0.10; p > 0.05).
The group of SBO patients shows two peaks of HRC
frequencies while there is one peak in the group of
SBA patients, suggesting that different genetic
dispositions at the polygenic level exist in the two
tested samples (Figure 2).
The results of AB0 blood type distribution testing
(Table III) show that there is a statistically significant
difference in frequencies of B blood type (χ2 = 4.1,
p < 0.05) and O blood type (χ2 = 4.5, p < 0.05)
between the group of SB patients and the average
value in the Serbian population [24].
Discussion
From the data presented in this study (Table I,
Figure 1), the frequency distribution of tested
homozygously recessive characteristics was
Homozygously recessive characteristics Spina bifida occulta  Spina bifida aperta χ2
N = 50, n (%) N = 50, n (%)
Blond hair 22 (44) 23 (46) 0.1
Continuous hairline 20 (40) 25 (50) 2.3
Straight hair 35 (70) 32 (64) 0.2
Soft hair 28 (56) 31 (62) 0.6
Double hair whorl 5 (10) 3 (6) 2.3
Opposite hair whorl orientation 6 (12) 9 (18) 2.5
Attached ear lobe 5 (10) 3 (6) 2.3
Ear without Darwinian knot 3 (6) 2 (4) 0.9
Blue eyes 11 (22) 22 (44) 16.5**
Colour blindness 1 (2) 1 (2) 0
Right thumb over left thumb 21 (42) 15 (30) 4.1*
Top joint of the thumb > 45° 22 (44) 15 (30) 5.5*
Proximal thumb extensibility 11 (22) 12 (24) 0.2
Left-handedness 11 (22) 9 (18) 0.8
Index finger longer than the ring finger 22 (44) 17 (34) 2.6
Σχ2 = 40.9**
*p < 0.05; **p < 0.001          
Spina bifida occulta: N = 50, x –
hro/15 = 4.5 ±0.2 
Spina bifida aperta: N = 50, x –
hro/15 = 4.4 ±0.2 (z = 0.10, p > 0.05)
Table II. Frequencies of homozygously recessive characteristics among patients with spina bifida occulta and spina
bifida aperta 
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controls (SB: 4.5 ±0.3, control: 3.0 ±0.2, z = 6.80, 
p < 0.001), indicating the population-genetic
difference that exists between them. Our results
show that almost 75% of SB patients had four or
more homo-recessive characteristics, whereas
among the control group almost 75% of individuals
had less than four homo-recessive characteristics
(Figure 1). In these comparisons, characteristic
groups of traits were present to a different degree
among SB patients and control individuals,
suggesting a correlation between different
combinations of polygenes which may be involved
in regulatory processes of resistance and
development of spinal dysraphism. 
A few possible explanations can be offered for
the established differences of HRC presence in the
samples of SB patients and the control group: 
• a higher degree of genetic homozygosity in the
group of SB patients may bring such organisms
into a specific state of genetic-physiological
homeostasis which enables easier expression of
spinal dysraphism;
• a higher degree of genetic homozygosity may
result in pleiotropic effects of specific genes
responsible for expressing predisposition to spinal
dysraphism;
• increased genetic homozygosity may raise the
genetic load, thus potentially causing decreased
body immunity, which might predispose to
development of spinal dysraphism [9-15, 25].
From the results presented (Table II, Figure 2) it
can be seen that there are no differences in average
homozygosity of such genetic markers between
groups of SBO and SBA patients, which is already
assumed since SBO and SBA are two subgroups
within one general entity of SB. But the type of
individual variation in the two studied groups was
significantly different (Σχ2 = 40.9, df = 14), showing
that their genetic dispositions were different too.
The results presented in Table II show that
differences in the presence of individual
homozygously recessive traits exist between
patients with SBO and SBA, suggesting that there
are different genetic dispositions at the polygenic
level between the two tested samples.
These differences in individual variability, no
matter the similar average values of genetic
homozygosity, point to different expression of
genes that may lead to different expression of SB
(SBO and SBA). Such claims may lead to new
insight into and understanding of pathogenesis of
SB and the influence of environmental factors on
genetic predisposition to expression of the two
evaluated different subtypes of SB.
In the sample of SB patients, O blood type is
significantly increased (χ2 = 4.5, p < 0.05) and there
is a statistically significant decrease in the
frequency of B blood type (χ2 = 4.1, p < 0.05)
compared with the percentage of those blood
groups in the Serbian population [24]. The
significant increase in the frequency of blood type
O in the group of SB patients may indicate that the
presence of this blood group represents a certain
predisposition to spinal dysraphism.
Beside genetic predisposition for SB inheritance
and development, it is important to further
evaluate the possible influence of environmental
factors (folic acid, vitamin B12, infection, drugs, etc.)
and gender for the expression of this pathological
condition [1, 5, 6].
Our results clearly show that there is
a populational genetic difference in the degree of
genetic homozygosity and variability between the
group of patients with SB and individuals without
clinical manifestations, indicating a possible genetic
component in the aetiopathogenesis of spina bifida. 
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